Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,7811,800 of 20,252 grants

Active NON-SBIR/STTR RPGS
Hybrid Trial of a Tailored Smoking Cessation Digital Therapeutic for Persons Living with HIV
NATIONAL CANCER INSTITUTE Wake Forest University Health Sciences United States 2024 – 2029

PROJECT ABSTRACT Tobacco use has alarmingly high rates among people with HIV (PWH), 43% compared with 15% in the general population. Due to the development of highly effective trea...

$6.75M
USD
Active NON-SBIR/STTR RPGS
Precision targeting of bladder cancer using CRISPR
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT Chromosome rearrangements (structural variants) are common in cancer and they drive tumor development by altering the expression or function of oncogenes and tumor suppres...

$5.66M
USD
Active NON-SBIR/STTR RPGS
Identification of cancer neoepitope-specific T cells using novel high-throughput hydrogel based platforms
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2027

Abstract Immunotherapies for cancer, including Adoptive Cell Transfer (ACT), chimeric antigen receptor (CAR) T cell therapy, and Immune Checkpoint Blockade (ICB), have seen great c...

$4.28M
USD
Active NON-SBIR/STTR RPGS
Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis
NATIONAL CANCER INSTITUTE Cedars-Sinai Medical Center United States 2024 – 2027

PROJECT SUMMARY / ABSTRACT CRISPR technology have massively expanded our ability to interrogate the genetic mechanisms of cancer and define therapeutic avenues. Techniques have evo...

$4.14M
USD
Active NON-SBIR/STTR RPGS
Contributions of the Adipose Tissue to the Development of Pancreatic Cancer
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2029

Project Summary Obesity is a risk factor for pancreatic ductal adenocarcinoma (PDAC), a cancer that has a dismal 5-year survival rate due to limitations in prevention and treatment...

$5.07M
USD
Active NON-SBIR/STTR RPGS
Novel functions of ESRRB in glioblastoma
NATIONAL CANCER INSTITUTE Georgetown University United States 2024 – 2029

Glioblastoma (GBM) is the most lethal of all brain malignancies and many patients die within one year of diagnosis. These poor outcomes are driven by GBM's aggressive growth,...

$5.42M
USD
Active OTHER RESEARCH-RELATED
Enhancing motivation to quit smoking via self-help intervention targeted to cancer type: A pilot RCT
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2027

Project Summary/Abstract Tobacco smoking is causally related to at least 12 cancer types. Quitting smoking after cancer is critical for improved treatment outcomes; however, over t...

$1.94M
USD
Completed NON-SBIR/STTR RPGS
Treatment Planning System for Electron FLASH radiation therapy
NATIONAL CANCER INSTITUTE New York Medical College United States 2024 – 2026

Abstract Ultra-high dose rate (UHDR) radiation delivery, termed FLASH radiotherapy (FLASH-RT), has the potential to reduce normal tissue damage, with significant clinical cancer tr...

$2.19M
USD
Completed NON-SBIR/STTR RPGS
Genomic lineage traces as biomarkers for human pancreatic and liver cancer
NATIONAL CANCER INSTITUTE University of Utah United States 2024 – 2026

PROJECT SUMMARY While cancer is known for its heterogeneity, with distinct subtypes observed within each organ system, the source of this heterogeneity, and the relationship betwee...

$2.16M
USD
Active NON-SBIR/STTR RPGS
A novel role for EZH2 in A-to-I RNA editing in prostate cancer
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

Abstract Prostate cancer is one of the most common cancers among men, and although it can successfully be treated in some men, others develop resistance to therapies and can relaps...

$6.7M
USD
Active NON-SBIR/STTR RPGS
Therapeutic Cancer NanoVaccine Promotes B/CD 4 T Cell Crosstalk for Durable Anticancer Efficacy
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT Current cancer therapeutic vaccines that utilize both CD4 and CD8 T cell neoantigens to stimulate T cell immunity through dendritic cell/macrophage-mediated antigen presen...

$5.29M
USD
Active NON-SBIR/STTR RPGS
Solid Phase Microextraction as a New Tool for Quantifying Antibody Drugs in Breast Cancer and Building PK-PD models
NATIONAL CANCER INSTITUTE Albany College of Pharmacy United States 2024 – 2027

Modern drug analysis techniques are an integral part of research and healthcare today. Regrettably, the current approach for sample collection consists of literally removing “a pie...

$4.8M
USD
Active TRAINING, INDIVIDUAL
Merkel cell polyomavirus T-Antigen mediated reprogramming in adult epidermis
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2024 – 2028

ABSTRACT Merkel cell carcinoma (MCC) is a poorly understood cutaneous malignancy with viral etiology. Most MCC tumors feature monoclonal integration of Merkel cell polyomavirus (MC...

$473.7K
USD
Completed NON-SBIR/STTR RPGS
Discovery of SATB2 Inhibitors for Pancreatic Cancer
NATIONAL CANCER INSTITUTE Glax, Llc United States 2024 – 2026

Abstract Pancreatic cancer is a slow-growing disease with a 5-year survival rate of approximately 9%. It is the fourth leading cause of cancer-related deaths in the US. Currently u...

$550K
USD
Completed NON-SBIR/STTR RPGS
CAR mast cell for solid tumor
NATIONAL CANCER INSTITUTE Yale University United States 2024 – 2026

Summary Chimeric Antigen Receptor (CAR)-T cell therapies have achieved unprecedented success in treating blood cancers that are resistant to traditional radiation or chemotherapies...

$2.42M
USD
Active NON-SBIR/STTR RPGS
Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2024 – 2029

Project Summary Disruption of normal mitochondrial bioenergetics and oxidative phosphorylation represents an early event during oncogenesis by changing the energy metabolism of pre...

$6.45M
USD
Completed NON-SBIR/STTR RPGS
CAR T Cells for Advanced Thyroid Cancer
NATIONAL CANCER INSTITUTE Methodist Hospital Research Institute United States 2024 – 2026

Project Summary The overall incidence of thyroid cancer in 2016 was estimated by the National Cancer Institute to be 64,300. Patients who present with poorly differentiated thyroid...

$5.89M
USD
Active NON-SBIR/STTR RPGS
T cell-intrinsic metabolic control of radiotherapy
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Unprecedented clinical successes in past 12-years with immune checkpoint blockers (ICBs) such as anti- CTLA-4 and anti-PD-1 re-instigate strong interests i...

$4.19M
USD
Active TRAINING, INDIVIDUAL
Investigating mechanisms of CARD11 mutants in enhanced anti-tumor immunity and T cell fitness (For Kathleen Cheng)
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2027

Project Summary/Abstract Adoptive cellular therapies (ACTs) have made remarkable advances in the treatment of hematological malignancies. However, remarkable outcomes are confined...

$441.9K
USD
Active NON-SBIR/STTR RPGS
Identifying the role of the gut microbiome in the etiology of benign breast disease
NATIONAL CANCER INSTITUTE Rutgers Biomedical and Health Sciences United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT The overall goal of this project is to identify the role of the gut microbiome in the etiology of benign breast disease (BBD), and thereby shed light on it...

$2.49M
USD